Blog: Breast Cancer
- If Breast Cancer Recurs Get Mastectomy
March 22, 2017
Read MoreIf Breast Cancer Recurs, Get Mastectomy Lumpectomy is now far more common than mastectomy to treat breast cancer. However, lumpectomy should not be chosen when breast cancer recurs. A new study shows that there is a much greater risk of death when a lumpectomy is performed to treat a recurrence than when a mastectomy is […]
- Breast Cancer Drug Avastin Increases Risk Of Blood Clots
March 22, 2017
Read MoreBreast Cancer Drug Avastin Increases Risk of Blood Clots According to a new study published in the Journal of the American Medical Association, the breast cancer drug Avastin increases a patient’s risk of developing blood clots in the veins, a condition known as venous thromboembolism (VTE).According to the new study, which analyzed 15 earlier studies, 7.3% of breast cancer patients […]
- For Breast Biopsy 11gauge Needle Better Than 14gauge Needle
March 22, 2017
Read MoreFor Breast Biopsy 11-Gauge Needle Better than 14-Gauge Needle According to a recent study performed at the Stanford University School of Medicine, stereotactic vacuum-assisted breast needle biopsy is more effective with an 11-gauge needle than the 14-gauge needle. There is less chance of a false-negative diagnoses with the 11-gauge needle than with the 14-gauge needle. […]
- Coffe Not Linked To Breast Cancer
March 22, 2017
Read MoreCoffee Not Linked to Breast Cancer A new study shows that coffee is not linked with breast cancer. More information about this study is available here.For information about breast cancer and the missed or misdiagnosis of breast cancer, see the Pittsburgh, Pennsylvania breast cancer lawyers.
- New Hope For Triplenegative Breast Cancer
March 22, 2017
Read MoreNew hope for Triple-Negative Breast Cancer Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a research grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer – triple-negative breast cancer. Many women with triple-negative breast cancer […]
- Study Finds Women Can Reduce Their Risk Of Breast Cancer
March 22, 2017
Read MoreStudy Finds Women Can Reduce Their Risk of Breast Cancer According to a report by the American Institute for Cancer Research, women can cut their risk of breast cancer by at least 40% if they take some preventative steps. The researchers looked at links between breast cancer and diet, body weight and physical activity. The […]
- Mammograms Remain Best Way To Spot Breast Cancer
March 22, 2017
Read MoreMammograms Remain Best Way to Spot Breast Cancer Mammograms detect 80 percent to 90 percent of breast cancers in women without symptoms, and all women 40 and older should get a yearly mammogram, says the American Cancer Society (ACS) as it marks National Mammography Day on Friday, Oct. 17. “Mammography remains the most effective screening […]
- Great Results For Ibrance Drug For Advanced Breast Cancer Cfm
March 22, 2017
Read MoreAdvanced metastatic breast cancer can now be treated with the drug Ibrance. This new study shows that it doubled progression-free survival. The New England Journal of Medicine has published the results of a study on the use of Ibrance (palbociclib) to treat advanced breast cancer. Ibrance was approved by the FDA in February 2015 to […]
- Twice As Long To
March 22, 2017
Read MoreTwice as Long to Read Digital Mammograms Interpretation of digital screening mammograms takes twice as long as interpretation of film-screen mammograms, according to a report in the January issue of the American Journal of Roentgenology. The differences ranged from 76 to 202 seconds longer. The average interpretation time was 240 seconds (4 minutes) for digital […]
- Breast Cancer Drug Approved For Extended Use Says FDA
March 22, 2017
Read MoreBreast Cancer Drug Approved for Extended Use, says FDA Tykerb (lapatinib) has been approved for treatment in combination with Femara (letrozole) by the U.S. Food and Drug Administration (FDA) for postmenopausal women who rely on hormonal therapy.Tykerb targets metastatic, postmenopausal breast cancer that is HER2-positive.Now Tykerb can be taken orally with Femara to deprive tumor […]